Unique Gut Microbiome Signatures among Adult Patients with Moderate to Severe Atopic Dermatitis in Southern Chinese

被引:11
|
作者
Wang, Yiwei [1 ]
Hou, Jinpao [1 ,2 ]
Tsui, Joseph Chi-Ching [3 ]
Wang, Lin [1 ]
Zhou, Junwei [3 ]
Chan, Un Kei [3 ]
Lo, Claudia Jun Yi [3 ]
Siu, Pui Ling Kella [3 ]
Loo, Steven King Fan [3 ,4 ,5 ]
Tsui, Stephen Kwok Wing [1 ,2 ,3 ,6 ]
机构
[1] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Ctr Microbial Genom & Prote, Hong Kong, Peoples R China
[3] BioMed Lab Co Ltd, Microbiome Res Ctr, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Hong Kong Inst Integrat Med, Fac Med, Hong Kong, Peoples R China
[5] Chinese Univ Hong Kong, Dermatol Ctr, CUHK Med Ctr, Hong Kong, Peoples R China
[6] Chinese Univ Hong Kong, Hong Kong Bioinformat Ctr, Hong Kong, Peoples R China
关键词
gut microbiota; atopic dermatitis; 16S rRNA amplicon; gut-skin axis; FECAL MICROBIOTA; INTESTINAL MICROBIOTA; REDUCED DIVERSITY; FOOD ALLERGY; ECZEMA AREA; SKIN AXIS; SENSITIZATION; CLOSTRIDIA; PATTERNS; INFANTS;
D O I
10.3390/ijms241612856
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Imbalance of the immune system caused by alterations of the gut microbiome is considered to be a critical factor in the pathogenesis of infant eczema, but the exact role of the gut microbiome in adult atopic dermatitis (AD) patients remains to be clarified. To investigate the differences of the gut microbiome between adult AD patients and healthy individuals, stool samples of 234 adults, containing 104 AD patients and 130 healthy subjects, were collected for 16S rRNA gene amplicon. Altered structure and metabolic dysfunctions of the gut microbiome were identified in adult AD patients. Our results illustrated that the adult AD patients were more likely to have allergies, particularly non-food allergies. In addition, the gut microbiome composition of the AD and normal groups were considerably different. Moreover, Romboutsia and Clostridi-um_sensu_stricto_1 was enriched in the normal group, whereas Blautia, Butyricicoccus, Lachnoclostridium, Eubacterium_hallii_group, Erysi-pelatoclostridium, Megasphaera, Oscillibacter, and Flavonifractor dominated in the AD group. Additionally, purine nucleotide degradation pathways were significantly enriched in the AD group, and the enrichment of proteinogenic amino acid biosynthesis pathways was found in the normal group. This study provides insights into new therapeutic strategies targeting the gut microbiome for AD and evidence for the involvement of the gut-skin axis in AD patients.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Dupilumab treatment significantly improves skin barrier function in adult and adolescent patients with moderate to severe atopic dermatitis
    Berdyshev, Evgeny
    Goleva, Elena
    Bissonnette, Robert
    Bronova, Irina
    Bronoff, Anna Sofia
    Richers, Brittany
    Garcia, Shannon
    Gama, Marco Ramirez
    Taylor, Patricia
    Bologna, Gabriel
    Agueusop, Inoncent
    Boguniewicz, Mark
    Harel, Sivan
    Levit, Noah
    Rossi, Ana
    Zhang, Annie
    Leung, Donald
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB10 - AB10
  • [42] Rapid and sustained improvement in skin pain with abrocitinib in adult and adolescent patients with moderate-to-severe atopic dermatitis
    Thyssen, J. P.
    Bewley, A.
    Stander, S.
    Kim, B.
    Biswas, P.
    DiBonaventura, M.
    Watkins, M.
    Alderfer, J.
    Guler, E.
    Silverberg, J. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E150 - E151
  • [43] Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials
    Wollenberg, A.
    Beck, L. A.
    Weller, M. Bruin
    Simpson, E. L.
    Imafuku, S.
    Boguniewicz, M.
    Zachariae, R.
    Olsen, C. K.
    Thyssen, J. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (03) : 453 - 465
  • [44] Dupilumab treatment significantly improves skin barrier function in adult and adolescent patients with moderate to severe atopic dermatitis
    Iversen, L.
    Conrad, C.
    Karner, J.
    Costanzo, A.
    Cardner, M.
    Bier, K.
    Lohmann, F.
    Kolbinger, F.
    Jagiello, P.
    Ferrero, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S243 - S243
  • [45] Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
    Fargnoli, M. C.
    Esposito, M.
    Ferrucci, S.
    Girolomoni, G.
    Offidani, A.
    Patrizi, A.
    Peris, K.
    Costanzo, A.
    Malara, G.
    Pellacani, G.
    Romanelli, M.
    Amerio, P.
    Cristaudo, A.
    Flori, M. L.
    Motolese, A.
    Betto, P.
    Patruno, C.
    Pigatto, P.
    Sirna, R.
    Stinco, G.
    Zalaudek, I.
    Bianchi, L.
    Boccaletti, V.
    Cannavo, S. P.
    Cusano, F.
    Lembo, S.
    Mozzillo, R.
    Gallo, R.
    Potenza, C.
    Rongioletti, F.
    Tiberio, R.
    Grieco, T.
    Micali, G.
    Persechino, S.
    Pettinato, M.
    Pucci, S.
    Savi, E.
    Stingeni, L.
    Romano, A.
    Argenziano, G.
    Calabrese, Giulia
    Campanati, Anna
    Caruso, Cristiano
    Chello, Camilla
    De Pasquale, Tiziana
    Di Costanzo, Luisa
    Dini, Valentina
    De Pasquale, Rocco
    Del Giglio, Micol
    Fracassi, Giovanna
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (05) : 507 - 513
  • [46] Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis
    Fleischer, Alan B., Jr.
    Abramovits, William
    Breneman, Debra
    Jaracz, Eileen
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2007, 18 (03) : 151 - 157
  • [47] Systemic exposure of pimecrolimus cream 1% and tacrolimus ointment 0.1% in adult patients with moderate to severe atopic dermatitis
    Draelos, ZD
    Hanifin, J
    Chon, K
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P4 - P4
  • [48] Dupilumab treatment restores skin barrier function in adult and adolescent patients with moderate-to-severe atopic dermatitis
    Goleva, E.
    Bissonnette, R.
    Berdyshev, E.
    Jurvilliers, P.
    Agueusop, I.
    Praestgaard, A.
    Levit, N. A.
    Rossi, A.
    Zhang, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S51 - S51
  • [49] Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS-J): Baseline characteristics, treatment history and disease burden
    Katoh, Norito
    Saeki, Hidehisa
    Kataoka, Yoko
    Etoh, Takafumi
    Teramukai, Satoshi
    Takagi, Hiroki
    Tajima, Yuki
    Ardeleanu, Marius
    Rizova, Elena
    Arima, Kazuhiko
    JOURNAL OF DERMATOLOGY, 2019, 46 (04): : 290 - 300
  • [50] Improved and cleared facial and hand dermatitis with lebrikizumab in patients with moderate-to-severe atopic dermatitis
    Murase, Jenny E.
    Chovatiya, Raj
    Strowd, Lindsay
    Thyssen, Jacob P.
    Bangert, Christine
    Atwater, Amber Reck
    Gallo, Gaia
    Bardolet, Laia
    Yang, Fan
    Zhong, Jinglin
    Staumont-Salle, Delphine
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188